AI assistant
PegBio Co., Ltd. — Regulatory Filings 2004
Oct 13, 2004
50676_rns_2004-10-13_205ba635-cfaa-423f-a6b5-3decf22e1e73.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss however arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [7 x 6] intentionally omitted <==
----- Start of picture text ----- *----- End of picture text -----
(Incorporated in Bermuda with limited liability) (Stock Code: 1141)
ANNOUNCEMENT
The board of directors (the “Board”) of Xin Corporation Limited (the “Company”) has noted the recent increases in the price and trading volume of the shares of the Company. The Board wishes to state that the Board is not aware of any reasons for such increases save as disclosed in the announcement dated 5th October, 2004.
The Board also refers to the statement made in the newspaper articles published on 12th October, 2004 speculating that the controlling shareholder of the Company may inject a Macau hotel together with certain gaming business into the Company and wishes to clarify that there are no negotiations or agreements relating to the purported transaction but that preliminary conceptual studies relating to the feasibility of such a transaction is being carried out by the Company. The Company wishes to further clarify that such preliminary studies may or may not lead to a transaction. In the event that a transaction materializes, the Company will make appropriate announcements as required by the Rules Governing the Listing of Securities on the Stock Exchange.
Shareholders and potential investors of the Company are advised to exercise cautions when dealing in the shares of the Company.
This announcement is made at the request of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”).
The Board has noted the recent increases in the price and trading volume of the shares of the Company and wishes to state that the Board is not aware of any reasons for such increases save as disclosed in the announcement dated 5th October, 2004.
The Board also refers to the statement made in the newspaper articles published on 12th October, 2004 speculating that the controlling shareholder of the Company may inject a Macau hotel together with certain gaming business into the Company and wishes to clarify that there are no negotiations or agreements relating to the purported transaction but that preliminary conceptual studies relating to the feasibility of such a transaction is being carried out by the Company. The Company wishes to further clarify that such preliminary studies may or may not lead to a transaction. In the event that a transaction materializes, the Company will make appropriate announcements as required by the Rules Governing the Listing of Securities on the Stock Exchange.
Shareholders and potential investors of the Company are advised to exercise cautions when dealing in the shares of the Company.
Save as disclosed above, the Board also confirms that there are no negotiations or agreements relating to intended acquisitions or realizations which are discloseable under Rule 13.23, neither is the Board aware of any matter discloseable under the general obligation imposed by Rule 13.09, which is or may be of a price-sensitive nature.
Made by the order of the Board, the directors of which individually and jointly accept responsibility for the accuracy of this announcement.
==> picture [145 x 34] intentionally omitted <==
Hong Kong, 12th October, 2004
As at the date of this announcement, the Board comprises Messrs. Lo Ming Chi, Charles (Chairman), Yu Wai Man, Wilson Ng, Ng Wee Keat, Ng Teow Leng and Ng Eng Leng as executive directors and Messrs. Wong Kwok Tai, Lau Pok Lam and Ko Kwong Woon, Ivan as independent non-executive directors.
* For identification only
Please also refer to the published version of this announcement in The Standard.